Authors: Tsuboi, A Oka, Y Ogawa, H Elisseeva, OA Li, HF Kawasaki, K Aozasa, K Kishmoto, T Udaka, K Sugiyama, H

Citation: A. Tsuboi et al., Cytotoxic T-lymphocyte responses elicited to Wilms' tumor gene WT1 productby DNA vaccination, J CLIN IMM, 20(3), 2000, pp. 195-202

Authors: Oka, Y Elisseeva, OA Tsuboi, A Ogawa, H Tamaki, H Li, HF Oji, Y Kim, EH Soma, T Asada, M Ueda, K Maruya, E Saji, H Kishimoto, T Udaka, K Sugiyama, H

Citation: Y. Oka et al., Human cytotoxic T-lymphocyte responses specific for peptides of the wild-type Wilms' tumor gene (WT1) product, IMMUNOGENET, 51(2), 2000, pp. 99-107

Authors: Oka, Y Udaka, K Tsuboi, A Elisseeva, OA Ogawa, H Aozasa, K Kishimoto, T Sugiyama, H

Citation: Y. Oka et al., Cancer immunotherapy targeting Wilms' tumor gene WT1 product, J IMMUNOL, 164(4), 2000, pp. 1873-1880

Authors: Tsuboi, A Oka, Y Ogawa, H Elisseeva, OA Tamaki, H Oji, Y Kim, EH Soma, T Tatekawa, T Kawakami, M Kishimoto, T Sugiyama, H

Citation: A. Tsuboi et al., Constitutive expression of the Wilms' tumor gene WT1 inhibits the differentiation of myeloid progenitor cells but promotes their proliferation in response to granulocyte-colony stimulating factor (G-CSF), LEUK RES, 23(5), 1999, pp. 499-505